SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/02/20 Kraig Biocraft Laboratories, Inc S-1 71:7.9M M2 Compliance/FA |
Document/Exhibit Description Pages Size 1: S-1 Registration Statement (General Form) HTML 1.20M 2: EX-14.2 Code of Ethics HTML 72K 3: EX-23.1 Consent of Experts or Counsel HTML 21K 4: EX-99.1 Miscellaneous Exhibit HTML 61K 5: EX-99.2 Miscellaneous Exhibit HTML 47K 6: EX-99.3 Miscellaneous Exhibit HTML 42K 14: R1 Document Entity Information HTML 34K 48: R2 Condensed Consolidated Balance Sheets HTML 120K 58: R3 Condensed Consolidated Balance Sheets HTML 49K (Parenthetical) 31: R4 Condensed Consolidated Statements of Operations HTML 89K 15: R5 Condensed Consolidated Statement of Changes in HTML 79K Stockholders Deficit 49: R6 Condensed Consolidated Statement of Changes in HTML 25K Stockholders Deficit (Parenthetical) 59: R7 Condensed Consolidated Statements of Cash Flows HTML 110K 32: R8 Summary of Significant Accounting Policies and HTML 114K Organization 13: R9 Going Concern HTML 28K 37: R10 Equipment HTML 35K 20: R11 Right to Use Assets and Lease Liability HTML 56K 50: R12 Accrued Interest - Related Party HTML 32K 60: R13 Note Payable HTML 28K 38: R14 Stockholders' Deficit HTML 157K 21: R15 Commitments and Contingencies HTML 81K 51: R16 Related Party Transactions HTML 63K 61: R17 Subsequent Events HTML 29K 39: R18 Summary of Significant Accounting Policies and HTML 153K Organization (Policies) 19: R19 Summary of Significant Accounting Policies and HTML 62K Organization (Tables) 41: R20 Equipment (Tables) HTML 33K 66: R21 Right to Use Assets and Lease Liability (Tables) HTML 40K 26: R22 Stockholders' Deficit (Tables) HTML 145K 22: R23 Summary of Significant Accounting Policies and HTML 49K Organization (Details Narrative) 42: R24 Summary of Significant Accounting Policies and HTML 43K Organization (Details Narrative) (10-K) 67: R25 Summary of Significant Accounting Policies and HTML 30K Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) 27: R26 Summary of Significant Accounting Policies and HTML 28K Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) (Parenthetical) 23: R27 Summary of Significant Accounting Policies and HTML 35K Organization - Schedule of Deferred Tax Assets and Liabilities (Details) (10-K) 40: R28 Summary of Significant Accounting Policies and HTML 24K Organization - Schedule of Deferred Tax Assets and Liabilities (Details) (10-K) (Parenthetical) 68: R29 Summary of Significant Accounting Policies and HTML 31K Organization - Schedule of Components of Deferred Income Taxes (Details) (10-K) 64: R30 Summary of Significant Accounting Policies and HTML 28K Organization - Schedule of Fair Value of Financial Instruments (Details) 54: R31 Summary of Significant Accounting Policies and HTML 34K Organization - Schedule of Concentration of Credit Risk (Details) (10-K) 18: R32 Going Concern (Details Narrative) HTML 33K 36: R33 Going Concern (Details Narrative) (10-K) HTML 33K 63: R34 Equipment (Details Narrative) HTML 25K 53: R35 Equipment (Details Narrative) (10-K) HTML 25K 17: R36 Equipment - Schedule of Property and Equipment HTML 37K (Details) 35: R37 Right to Use Assets and Lease Liability - (Details HTML 59K Narrative) 62: R38 Right to Use Assets and Lease Liability - (Details HTML 65K Narrative) (10-K) 55: R39 Right to Use Assets and Lease Liability - Schedule HTML 28K of Right Use of Assets (Details) 71: R40 Right to Use Assets and Lease Liability - Schedule HTML 33K of Lease Liability (Details) 44: R41 Right to Use Assets and Lease Liability - Schedule HTML 27K of Lease Cost (Details) 25: R42 Accrued Interest - Related Party (Details HTML 45K Narrative) 30: R43 Accrued Interest - Related Party (Details HTML 45K Narrative) (10-K) 70: R44 Note Payable (Details Narrative) HTML 41K 43: R45 Note Payable (Details Narrative) (10-K) HTML 41K 24: R46 Stockholders' Deficit (Details Narrative) HTML 186K 29: R47 Stockholders' Deficit (Details Narrative) (10-K) HTML 179K 69: R48 Stockholders' Deficit - Schedule of Option HTML 86K Assumption (Details) 45: R49 Stockholders' Deficit - Schedule of Warrants HTML 52K Activity (Details) 46: R50 Stockholders' Deficit - Schedule of Warrants HTML 59K Outstanding (Details) 56: R51 Stockholders' Deficit - Schedule of Options HTML 31K Outstanding (Details) 33: R52 Commitments and Contingencies (Details Narrative) HTML 355K 16: R53 Commitments and Contingencies (Details Narrative) HTML 311K (10-K) 47: R54 Related Party Transactions (Details Narrative) HTML 272K 57: R55 Related Party Transactions (Details Narrative) HTML 293K (10-K) 34: R56 Subsequent Events (Details Narrative) (10-K) HTML 35K 65: XML IDEA XML File -- Filing Summary XML 128K 28: EXCEL IDEA Workbook of Financial Reports XLSX 95K 7: EX-101.INS XBRL Instance -- kblb-20200331 XML 2.05M 9: EX-101.CAL XBRL Calculations -- kblb-20200331_cal XML 133K 10: EX-101.DEF XBRL Definitions -- kblb-20200331_def XML 814K 11: EX-101.LAB XBRL Labels -- kblb-20200331_lab XML 909K 12: EX-101.PRE XBRL Presentations -- kblb-20200331_pre XML 959K 8: EX-101.SCH XBRL Schema -- kblb-20200331 XSD 178K 52: ZIP XBRL Zipped Folder -- 0001493152-20-010402-xbrl Zip 146K
Exhibit 99.2
CHARTER OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS OF
KRAIG BIOCRAFT LABORATORIES, INC.
(Adopted by the Board of Directors of Kraig Biocraft Laboratories, Inc. (the “Company”) on [ ], 2020; effective upon the effectiveness of the Company’s registration statement on Form S-1 relating to the uplisting of its common stock and certain warrants on the Nasdaq Capital Market)
I. PURPOSE OF THE COMMITTEE
The purposes of the Company’s Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) shall be to oversee the Company’s compensation and employee benefit plans and practices, including its executive compensation plans, and to perform such further functions as may be consistent with this Charter or assigned by applicable law, the Company’s articles of incorporation or bylaws or the Board.
II. COMPOSITION OF THE COMMITTEE
The Committee shall consist of three (3) or more directors as determined from time to time by the Board. Each member of the Committee shall be qualified to serve on the Committee pursuant to the requirements of the Nasdaq, and any additional requirements that the Board deems appropriate. Composition of the Committee shall also comply with any other applicable laws and regulations. In addition, in affirmatively determining the independence of any director who will serve on the Committee, the Board must consider all factors specifically relevant to determining whether a director has a relationship to the Company which is material to that director’s ability to be independent from management in connection with the duties of a Committee member, including but not limited to (i) the source of compensation of such director, including any consulting, advisory or other compensatory fee paid by the Company to such director; and (ii) whether such director is affiliated with the Company, a subsidiary of the Company or an affiliated of a subsidiary of the Company.
The chairperson of the Committee shall be designated by the Board. Any vacancy on the Committee shall be filled by majority vote of the Board. No member of the Committee shall be removed except by majority vote of the Board.
III. MEETINGS AND PROCEDURES OF THE COMMITTEE
The Committee shall meet as often as it determines necessary to carry out its duties and responsibilities, but no less than once annually. The Committee, in its discretion, may ask members of management or others to attend its meetings (or portions thereof) and to provide pertinent information as necessary, provided, that the Chief Executive Officer of the Company may not be present during any portion of a Committee meeting in which deliberation or any vote regarding his or her compensation occurs.
C:
C: 1 |
A majority of the members of the Committee present in person or by means of a conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other shall constitute a quorum.
The Committee shall maintain minutes of its meetings and records relating to those meetings and shall report regularly to the Board on its activities, as appropriate.
IV. DUTIES AND RESPONSIBILITIES OF THE COMMITTEE
A. Executive Compensation
The Committee shall have the following duties and responsibilities with respect to the Company’s executive compensation plans:
a) | To review at least annually the goals and objectives of the Company’s executive compensation plans, and amend, or recommend that the Board amend, these goals and objectives if the Committee deems it appropriate. | |
b) | To review at least annually the Company’s executive compensation plans in light of the Company’s goals and objectives with respect to such plans, and, if the Committee deems it appropriate, adopt, or recommend to the Board the adoption of, new, or the amendment of existing, executive compensation plans. | |
c) | To evaluate annually the performance of the Chief Executive Officer in light of the goals and objectives of the Company’s executive compensation plans, and, either as a Committee or together with the other independent directors (as directed by the Board), determine and approve the Chief Executive Officer’s compensation level based on this evaluation. In determining the long-term incentive component of the Chief Executive Officer’s compensation, the Committee shall consider factors as it determines relevant, which may include, for example the Company’s performance and relative shareholder return, the value of similar awards to chief executive officers of comparable companies, and the awards given to the Chief Executive Officer of the Company in past years. The Committee may discuss the Chief Executive Officer’s compensation with the Board if it chooses to do so. | |
d) | To evaluate annually the performance of the other executive officers of the Company in light of the goals and objectives of the Company’s compensation plans, and either as a Committee or together with the other independent directors (as directed by the Board) determine and approve the compensation of such other executive officers. To the extent that long-term incentive compensation is a component of such executive officer’s compensation, the Committee shall consider all relevant factors in determining the appropriate level of such compensation, including the factors applicable with respect to the Chief Executive Officer. |
C:
2 |
e) | To evaluate annually the appropriate level of compensation for Board and Committee service by non-employee directors. | |
f) | To review and approve any severance or termination arrangements to be made with any executive officer of the Company. | |
g) | To perform such duties and responsibilities as may be assigned to the Board or the Committee under the terms of any executive compensation plan. | |
h) | To review perquisites or other personal benefits to the Company’s executive officers and directors and recommend any changes to the Board. | |
i) | To review compensation arrangements for the Company’s employees to evaluate whether incentive and other forms of pay encourage unnecessary or excessive risk taking, and review and discuss, at least annually, the relationship between risk management policies and practices, corporate strategy and the Company’s compensation arrangements. | |
j) | To review and approve the description of executive compensation included in the Company’s annual report on Form 10-KF. | |
k) | To perform such other functions as assigned by law, the Company’s articles of incorporation or bylaws or the Board. |
B. General Compensation and Employee Benefit Plans
The Committee shall have the following duties and responsibilities with respect to the Company’s general compensation and employee benefit plans, including incentive compensation and equity-based plans:
a) | To review at least annually the goals and objectives of the Company’s general compensation plans and other employee benefit plans, including incentive-compensation and equity-based plans, and amend, or recommend that the Board amend, these goals and objectives if the Committee deems it appropriate. | |
b) | To review at least annually the Company’s general compensation plans and other employee benefit plans, including incentive-compensation and equity-based plans, in light of the goals and objectives of these plans, and recommend that the Board amend these plans if the Committee deems it appropriate. |
C:
3 |
c) | To review all equity-compensation plans to be submitted for shareholder approval under the Nasdaq listing standards, and to review and, in the Committee’s sole discretion, approve all equity-compensation plans that are exempt from such shareholder approval requirement. | |
d) | To perform such duties and responsibilities as may be assigned to the Board or the Committee under the terms of any compensation or other employee benefit plan, including any incentive-compensation or equity-based plan. |
V. ROLE OF CHIEF EXECUTIVE OFFICER
The Chief Executive Officer may make, and the Committee may consider, recommendations to the Committee regarding the Company’s compensation and employee benefit plans and practices, including its executive compensation plans, its incentive compensation and equity-based plans with respect to executive officers other than the Chief Executive Officer and the Company’s director compensation arrangements.
VI. EVALUATION OF THE COMMITTEE
The Committee shall, no less frequently than annually, evaluate its own performance. In conducting this review, the Committee shall evaluate whether this Charter appropriately addresses the matters that are or should be within its scope and shall recommend such changes as it deems necessary or appropriate to the Board for its consideration. The Committee shall address all matters that the Committee considers relevant to its performance, including at least the following: the adequacy, appropriateness and quality of the information and recommendations presented by the Committee to the Board, the manner in which they were discussed or debated, and whether the number and length of meetings of the Committee were adequate for the Committee to complete its work in a thorough and thoughtful manner.
The Committee shall deliver to the Board a report, which may be oral, setting forth the results of its evaluation, including any recommended amendments to this Charter and any recommended changes to the Company’s or the Board’s policies or procedures.
VII. INVESTIGATIONS AND STUDIES; OUTSIDE ADVISERS
The Committee may conduct or authorize investigations into or studies of matters within the Committee’s scope of responsibilities, and may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser. The Committee shall be directly responsible for the appointment, compensation and oversight of the work of any compensation consultant, legal counsel or other adviser retained by the Committee, the expense of which shall be borne by the Company. The Committee may select a compensation consultant, legal counsel or other adviser to the Committee, other than in-house legal counsel, only after taking into consideration all factors relevant to that person’s independence from management, including the following:
a) | The provision of other services to the Company by the person that employs the compensation consultant, legal counsel or other adviser; |
C:
4 |
b) | The amount of fees received from the Company by the person that employs the compensation consultant, legal counsel or other adviser, as a percentage of the total revenue of the person that employs the compensation consultant, legal counsel or other adviser; | |
c) | The policies and procedures of the person that employs the compensation consultant, legal counsel or other adviser that are designed to prevent conflicts of interest; | |
d) | Any business or personal relationship of the compensation consultant, legal counsel or other adviser with a member of the Committee; | |
e) | Any stock of the Company owned by the compensation consultant, legal counsel or other adviser; and | |
f) | Any business or personal relationship of the compensation consultant, legal counsel, other adviser or the person employing the adviser with an executive officer of the Company. |
The Committee shall conduct the independence assessment with respect to any compensation consultant, legal counsel or other adviser that provides advice to the Committee, other than: (1) in-house legal counsel; and (2) any compensation consultant, legal counsel or other adviser whose role is limited to the following activities for which no disclosure would be required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan that does not discriminate in scope, terms, or operation, in favor of executive officers or directors of the Company, and that is available generally to all salaried employees; or providing information that either is not customized for the Company or that is customized based on parameters that are not developed by the compensation consultant, and about which the compensation consultant does not provide advice.
Nothing herein requires a compensation consultant, legal counsel or other compensation adviser to be independent, only that the Committee consider the enumerated independence factors before selecting or receiving advice from a compensation consultant, legal counsel or other compensation adviser. The Committee may select or receive advice from any compensation consultant, legal counsel or other compensation adviser it prefers, including ones that are not independent, after considering the six independence factors outlined above.
Nothing herein shall be construed: (1) to require the Committee to implement or act consistently with the advice or recommendations of the compensation consultant, legal counsel or other adviser to the Committee; or (2) to affect the ability or obligation of the Committee to exercise its own judgment in fulfillment of its duties.
* * *
While the members of the Committee have the duties and responsibilities set forth in this Charter, nothing contained in this Charter is intended to create, or should be construed as creating, any responsibility or liability of members of the Committee, except to the extent otherwise provided under applicable federal or state law.
C:
5 |